anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Disclaimer

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 41,127
Current window 28,411-28,440
Pages 1,371
Rows per page 30
Component: Disclaimerclear collectionreset all
18 30 60

Component

28,411-28,440 of 41,127

filter-aware
08
The slide uses a donut chart to visualize market share and lists service capabilities across four key pillars.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations Beat · Market Size1 hit
12
The chart uses a grouped bar chart format to compare Revenue and Adjusted EBITDA over time, with additional rows for Adj. EBITDA Margin and Net Income.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
16
The table provides a detailed breakdown of R&D, S&M, and G&A expenses, adjusting for stock-based compensation, restructuring, and legal/transaction costs.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Satisfaction1 hit
18
Sonos | Results Presentation Deck | 41 slidesSonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
31
Includes a table of historical household data (2018-2022) and a revenue bridge calculation.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
34
The slide uses a chevron graphic to imply progression from current state to future state.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
36
Includes non-GAAP metrics and constant currency growth rates.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
39
Includes footnotes explaining restructuring expenses and legal/transaction costs.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
07
Uses a before-after comparison to illustrate the scale of the acquisition.Taboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Problem (Identify pain)Loop · Before After1 hit
08
The table highlights accretion in both Revenue/Share and Adjusted EBITDA/Share.Taboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Problem (Identify pain)Loop · Before After1 hit
02
Talkspace | Results Presentation Deck | 11 slidesTalkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations 1 hit
07
DTE stands for Direct-to-Enterprise; MBH & EAP stands for Mental Health Benefit & Employee Assistance Program.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
11
Includes footnotes explaining financial income and non-recurring expenses.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations 1 hit
01
Slide 1
Theravance Biopharma | Investor Conference Presentation Deck | 44 slidesTheravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
05
Theravance Biopharma | Investor Conference Presentation Deck | 44 slidesTheravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
07
The slide uses a biological process diagram to explain the mechanism of action for midodrine and droxidopa in the context of autonomic disorders.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
12
The slide shows a significant increase in Norepinephrine levels with Ampreloxetine treatment compared to placebo.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
16
Includes a footer with abbreviations for BP, DHPG, MSA, NE, and nOH.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
19
The slide highlights the failure of Study 0169 and the subsequent early termination of Study 0170.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
20
The slide outlines a complex clinical trial structure involving rollovers from Study 0169 and de novo participants, leading into a randomized withdrawal period.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
21
The slide uses a flow diagram to illustrate study design and participant disposition.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
22
The slide provides a standard 'Table 1' style clinical trial baseline characteristic summary.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
24
The slide uses a forest plot to visualize the odds ratio (0.60) with a 95% confidence interval (0.27, 1.29) crossing the null value of 1.0.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
26
The slide highlights the MSA subgroup with a blue box, suggesting a focus on this specific finding.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · KPI Overview1 hit
34
The slide outlines a clinical trial program involving three studies (0169, 0170, 0171) with specific eligibility criteria and endpoints for a longitudinal analysis.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
39
The chart uses a split-axis design to represent three distinct study phases (0169, 0170 OL, 0170 RW).Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
43
Includes a footer with abbreviations for MSA, nOH, OHSA, and SBP.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
03
Vivid Seats | Results Presentation Deck | 20 slidesVivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · Attention1 hit
10
Includes margin percentages overlaid on bar charts.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
12
The table uses arrows to indicate the direction of guidance revisions (upward or flat).Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit